The possible role of the gut neuroendocrine system in diabetes gastroenteropathy

Histology and Histopathology

Volumn 17, Issue 4, 2002, Pages 1153-1161

  El Salhy, Magdy ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes; Gastroenteropathy; Gut; Motility; Neuroendocrine system

Indexed keywords

AMINE; CHOLECYSTOKININ; ENKEPHALIN; GALANIN; GASTRIC INHIBITORY POLYPEPTIDE; GASTRIN; GASTRIN RELEASING PEPTIDE; GLUCOSE; MOTILIN; NEUROPEPTIDE Y; NEUROTENSIN; NITRIC OXIDE; OXYNTOMODULIN; PANCREAS POLYPEPTIDE; PEPTIDE; PEPTIDE YY; SECRETIN; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ABDOMINAL PAIN; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONSTIPATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIARRHEA; DISEASE SEVERITY; FECES INCONTINENCE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEARTBURN; HUMAN; HYPERGLYCEMIA; IMMUNITY; INTESTINE SECRETION; MALNUTRITION; METABOLIC DISORDER; METABOLIC REGULATION; MORBIDITY; NAUSEA; NAUSEA AND VOMITING; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOGENESIS; PREDICTION; REVIEW; RISK FACTOR;

ANIMALS; DIABETES MELLITUS; DIGESTIVE PHYSIOLOGY; DIGESTIVE SYSTEM; GASTROINTESTINAL DISEASES; HUMANS; NEUROSECRETORY SYSTEMS;

EID: 0036789751     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Abrahamsson H. (1995). Gastrointestinal motility disorders in patients with diabetes mellitus. J. Intern. Med. 237, 403-409.
2. Allescher H.D. (1991). Postulated physiological and pathophysiological roles on motility. In: Neuropeptides function in gastrointestinal tract. Daniel E.E. (ed). CRC Press. Boca Raton pp 309-400.
3. Ballmann M. and Conlon J.M. (1985). Changes in the somatostatin, substance P and vasoactive polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in rats. Diabetologia 28, 355-358.
4. Belai A., Lincoln J., Milner P. and Burnstock G. (1988). Progressive changes in adrenergic, and peptidergic nerves in proximal colon of streptozotocin-diabetic rats. Gastroenterology 95, 1234-1341.
5. Belai A. and Burnstock G. (1990). Changes in adrenergic and peptidergic nerves in the submucous plexus of streptozotocin-diabetic rat ileum. Gastroenterology 98, 1427-1436.
6. Belai A., Lincoln J., Milner P. and Burnstock G. (1991). Differential effect of streptozotocin-induced diabetes on innervation of the ileum and distal colon. Gastroenterology 100, 1024-1032.
7. Belai A., Facer P., Bishop A., Polak J.M. and Burnstock G. (1993). Effect of streptozotocin- diabetes on the level of VIP mRNA in myenteric neurones. Neuroreport 4, 291-294.
8. Björnsson E.S., Urbanavicius V., Eliasson B., Attval S., Smith U. and Abrahamsson H. (1994). Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand. J. Gastroenterol. 29, 1096-1104.
9. Britland S.T., Young R.J., Shama A.K., Lee D., Ah-see A.K. and Clark B.F. (1990). Vagus nerve morphology in diabetic gastropathy. Diabet. Med. 7, 780-787.
10. Bucceri A.M., Calogero A.E. and Brogna A. (2002). Gallbladder and gastric emptying: Relationship to cholecystokininemia in diabetics. Eur. J. Intern. Med. 13, 123-128.
11. Buchan A.M. (1990). Effect of diabetes in BB Wistar rat on the peptidergic component of the enteric innervation. Digestion 46, 142-147.
12. Bunnett N. (1994). Gastrin-releasing peptide. In: Gut petides: Biochemistry and physiology. Walsh J.H. and Dockray G.J. (eds). Raven Press. New York. pp 423-445.
13. Burnstock G., Mirsky R. and Belai A. (1988). Reversal of nerve damage in streptozotocin-diabetic rats by acute application of insulin in vitro. Clin. Sci. 75, 629-635.
14. Camilleri M. (1996). Gastrointestinal problems in diabetes. Endocrinol. Metabol. Clin. North America 2, 361-378.
15. Chiba T. and Yamada T. (1994). Gut somatostatin. In: Gut petides: Biochemistry and physiology. Walsh J.H. and Dockray G.J. (eds). Raven Press. New York. pp 123-145.
16. Clouse R.E. and Lustman P.J. (1989). Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am. J. Gastroenterol. 84, 868-872.
17. Debas H.T. and Mulvihill S.J. (1991). Neuroendocrine design of the gut. Am. J. Surg. 161, 243-249.
18. Di Giulio A.M., Tenconi B., La Croix R., Mantegazza P., Cattabeni F. and Gorio A. (1989). Denervation and hyperinnervation in the nervous system of diabetic animals. I. the autonomic neuronal dystrophy of the gut. J. Neurosci. Res. 24, 355-361.
19. Dockray G.J. (1994a). Physiology of enteric neuropeptides. In. Johanson LR, editor. Physiology of gastrointestinal tract. 3rd edn. Raven Press. New York. pp 169-209.
20. Dockray G.J. (1994b). Substance P and other tackykinins. In: Gut petides: Biochemistry and physiology. Walsh J.H. and Dockray G.J. (eds). Raven Press. New York. pp 401-422.
21. Dockray G.J. (1994c). The opoid peptides. In: Gut petides: Biochemistry and physiology. Walsh J.H. and Dockray G.J. (eds). Raven Press. New York. pp 473-491.
22. Ekblad E., Håkanson R. and Sundler F. (1991). Microanatomy and chemical coding of peptide-containing neurones in the digestive tract. In: Neuropeptides function in gastrointestinal tract. Daniel E.E (ed). CRC Press, Boca Raton. pp 131-180.
23. El-Salhy M. (1998). Neuroendocrine peptides in the gastrointestinal tract of an animal model of human diabetes type 2. Acta Diabetol. 35, 194-198.
24. El-Salhy M. (1999). Neuroendocrine peptides in stomach and colon of an animal model of human diabetes type 1. J. Diabetes Compl. 13, 170-173.
25. El-Salhy M. (2001a). Gastrointestinal transit in nonobese diabetic mouse of an animal model of human diabetes type 1. J. Diabetes Compl. 15, 277-284.
26. El-Salhy M. (2001b). Gastrointestinal transit in of an animal model of human diabetes type 2: relationship to gut neuroendocrine contents. (Submitted).
27. El-Salhy M. and Sitohy B. (2001). Abnormal gastrointestinal endocrine cells in patients with diabetes type 1: relationship to gastric emptying and myoelectrical activity. Scand. J. Gastroenterol. 36, 1162-1169.
28. El-Salhy M. and Spångéus A. (1998a). Antral endocrine cells in non-obese diabetic NOD-mice. Dig. Dis. Sci. 43, 1031-1037.
29. El-Salhy M. and Spångéus A. (1998b). Substance P in the gastrointestinal tract of non-obese diabetic NOD-mice. Scand. J. Gastroenterol. 33, 394-400.
30. El-Salhy M. and Spångéus A. (1998c). Neuropeptide contents in the duodenum of non-obese diabetic mice. Acta Diabetol. 35, 9-12.
31. El-Salhy M., Zachrisson S. and Spångéus A. (1998). Abnormalities of small intestinal endocrine cells in non-diabetic NOD-mice. J Diabetes Compl. 12, 215-223.
32. Enck P., Rathmann W., Spiekermann M., Czerner D., Tschöpe D., Ziegler D., Ziegler D., Strohmeyer G. and Gries F.A. (1996). Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z. Gastroenterol. 32, 637-64.
33. Feldman M. and Schiller L.R. (1983). Disorders of gastrointestinal motility associated with diabetes mellitus. Ann. Intern. Med. 98, 378-384.
34. Goyal P.K. and Hirano I. (1996). Mechanisms of disease: The enteric nervous system. N. Engl. J. Med. 334, 1106-1115.
35. Gorio A., Di Giulio A.M., Donadoni L., Tenconi B., Germani E., Bertelli A. and Mantegazza P. (1992). Early neurochemical changes in the autonomic neuropathy of the gut in experimental diabetes. Int. J. Clin. Pharm. Res. 12, 217-224.
36. Jervell J. (1996). Insulin 1996-75 years after its discovery (editorial). Diabet. Med. 13, 847-449.
37. Koch K.L. (1999). Diabetic gastropathy. Gastric neuromuscular dysfunction in diabetes mellitus. A review of symptoms, pathophysiology and treatment. Dig. Dis. Sci. 44, 1061-1075.
38. Leiter A., Chey W. and Kopin A. (1994). Secretin. In: Gut peptides: Biochemistry and physiology. Walsh J.H. and Dockray G.J. (eds). Raven Press. New York. pp 147-173.
39. Lidberg P. (1995). On the role of substance P and serotonin in the pyloric motor control. An experimental study in cat and rat. Acta Physiol. Scand. Suppl 538, 1-69.
40. Liddle R. (1994). Cholecystokinin. In: Gut petides: Biochemistry and physiology. Walsh J.H. and Dockray G.J. (eds). Raven Press. New York. pp 175-216.
41. Lincolin J., Boker J.T., Crowe R., Griffith S.G., Haven A.J. and Burnstock G. (1984). Myenteric plexus in streptozotocin-treated rats. Gastroenterology 86, 654-661.
42. Locke III G.R. (1995). Epidemiology of gastrointestinal complications of diabetes mellitus. Eur. J. Gastroenterol. Hepatolog. 7, 711-716.
43. Loesch A., Belai A., Lincoln J. and Burnstock G. (1986). Enteric nerves in diabetic rats: electron microscopic evidence for neuropathy of vasoactive intestinal polypeptide-containing fibres. Acta Neuropathol. 70, 161-168.
44. Lysy J., Karmeli I and Goldin E. (1993.) Substance P levels in rectal mucosa of diabetic patients with normal bowel function and constipation. Scand. J. Gastroenterol. 28, 49-52.
45. Mannon P. and Taylor I.L. (1994). The pancreatic polypeptide family. In: Gut petides: Biochemistry and physiology. Walsh J.H. and Dockray G.J. (eds). Raven Press. New York. pp 341-370.
46. McConalogue K. and Furness J.B. (1994). Gastrointestinal transmitters. Baollieres Clin. Endocrinol. Metabol. 8, 51-76.
47. Merio R., Festa A., Bergmann H., Eder T., Eibl N., Stacher-Janotta G., Weber U., Budka C., Heckenberg A., Bauer P., Francesconi M., Schernthaner G. and Stacher G. (1997). Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose and glycaemic control. Diabetes Care 20, 419-423.
48. Nompleggi D., Bell S., Blackburn G. and Bistrian B. (1989). Overview of gastrointestinal disorders due to diabetes mellitus: Emphasis on nutritional support. J. Pareteral Enteral. Nutr. 13,84-91.
49. Nwokolo C.U., Debnam E.S., Booth J.D., Sim R., Sankey E.A., Dhililon A.P. and Pounder R.E. (1992). Neuroendocrine changes in rat stomach during experimental diabetes mellitus. Dig. Dis. Sci. 37, 751-756.
50. Pederson R. (1994). Gastric inhibitory polypeptide. In: Gut peptides: Biochemistry and physiology. Walsh J.H. and Dockray G.J. (eds). Raven Press. New York. pp 217-259.
51. Pinto H.C., Portela-Gomes G.M., Grimelius L., Kohnert K.D. and DeSousa J.C. (1995). The distribution of endocrine cell trypes of the gastrointestinal mucosa in genetically diabetic (db/db) mice. Gastroenterology 108, 967-974.
52. Poitras P. (1994). Motilin. In: Gut peptides. Biochemistry and physiology. Walsh J.H, Dockray G.J. (eds). New York. Raven Press. pp 261-304.
53. Portela-Gomes G.M., Wilander E., Grimelius L., Bergström R. and Ruhn G. (1990). The enterochromaffin cells in the mouse gastrointestinal tract after streptozotocin treatment. Pathol. Res. Pract. 186, 260-264.
54. Rangachari P.K. (1991). Effects of neuropeptides on intestinal ion transport. In: Neuropeptides function in gastrointestinal tract. Daniel E.E. (ed). CRC Press. Boca Raton. pp 429-446.
55. Rökaeus Å. (1994). Galanin. In: Gut peptides: Biochemistry and physiology. Walsh J.H. and Dockray G.J. (eds). Raven Press. New York. pp 525-552.
56. Rotter J., Vadheim C. and Rimoin D. (1990). genetics of diabetes mellitus. In: Diabetes mellitus-theory and practice. Rifkin H. and Porte D. (eds). Elsevier. New York. pp 378-413.
57. Schwartz E., Palmér M., Ingberg C.M., Åman J. and Berne C. (1996). Increased prevalence of gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabetic Med. 13, 478-481.
58. Shulkes A. (1994). Neurotensin. In: Gut peptides: Biochemistry and physiology. Walsh J.H. and Dockray G.J. (eds). Raven Press. New York. pp 217-259.
59. Spångéus A. and El-Salhy M. (1998a). Myenteric plexus in the gastrointestinal tract of non-obese diabetic mice diabetes. Histol. Histopathol. 13, 989-994.
60. Spångéus A. and El-Salhy M. (1998b). Large intestinal endocrine cells in non-obese diabetic mice. J. Diabetes Compl. 12, 321-327.
61. Spångéus A. and El-Salhy M. (1999). Gastrointestinal endocrine cells in an animal model for human type 2 diabetes. Dig. Dis. Sci. 44, 979-985.
62. Spångéus A. and El-Salhy M. (2001). Myenteric plexus of obese diabetic mice: an animal model of human type 2 diabetes. Histol. Histopathol. 16, 159-165.
63. Spångéus A., El-Salhy M., Suhr O., Eriksson J. and Lithner F. (1999). Prevalence of gastrointestinal symptoms in young and middle-aged diabetic patients. Scand. J. Gastroenterol. 34, 196-1202.
64. Spångéus A. Forsgren S. and El-Salhy M. (2000a). Does diabetic state affect co-localisation of peptide YY (PYY) and enteroglucagon in colonic endocrine cells. Histol. Histopathol. 15, 37-41.
65. Spångéus A., Suhr O. and El-Salhy M. (2000b). Diabetic state affects the innervation of gut in an animal model of human type I diabetes. Histol. Histopathol. 15, 739-744.
66. Spångéus A., Forsgren S. and El-Salhy M. (2001). Effect of diabetic state on co-localization of substance P and serotonin in the gut of animal models. Histol. Histopathol. 16, 393-398.
67. Tally N.J. (1992). Review article: 5-Hydroxytryptamine agonists and antagonists in modulation of gastrointestinal motility and sensation: clinical implications. Aliment. Pharmacol. Ther. 6, 273-289.
68. von der Ohe M.R., Hanson R.B. and Camilleri M. (1994). Serotogenic mediation of postprandial colonic tonic and phasic response in humans. Gut 35, 536-541.
69. Walsh J.H. (1994) Gastrointestinal hormones. In: Physiology of gastrointestinal tract. 3rd edn. Johanson L.R. (ed). Raven Press. New York. pp 1-128.
70. Whittle B. (1994). Nitric oxide in gastrointestinal physiology and pathology. In: Physiology of gastrointestinal tract. 3rd edn. Johanson L.R. (ed). Raven Press. New York. pp 267-294.
71. Wrzos H.F., Cruz A., Polavarapu R., Shearer D. and Ouyang A. (1997). Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats. Dig. Dis. Sci. 42, 2106-2110.
72. Yoshida M.M., Schuffler M.D. and Sumi S.M. (1988). There are no morphological abnormalities of gastric wall or abdominal vagus in patients with diabetic gastroparesis. Gastroenterology 94, 907-914.